ICER hashtag#WeeklyView: Upcoming ICER's upcoming report for CMS, Novo’s price cuts, & Rx in State of the Union conta.cc/3OJUzar

TODAY -- join us for a public meeting to discuss treatments for IgA #nephropathy. An independent appraisal committee will review ICER's report, hear testimony from stakeholders, and deliberate on the treatments’ clinical effectiveness and value. Register here: events.zoom.us/ev/AuoKGT8Xu...

On March 11th, the Health Economics Methods Advisory Group (HEMA) will release its inaugural report: “Defining appropriate benefits for economic evaluation of health care technologies.” HEMA will also host a webinar on the topic on March 23rd. Register now: us02web.zoom.us/webinar/regi...

ICER's President and CEO, Sarah K. Emond, will be speaking at #MMDC26! On March 23rd, Sarah will join John Coster, Anna Kaltenboeck, and Robert Popovian for a session titled "From Innovation to Affordability: Navigating the New Era of Drug Pricing." Learn more: www.ahip.org/conferences/...

ICER #WeeklyView: Upcoming public meeting, FDA reversal on Moderna vaccine, & the impact of the IRA conta.cc/46OkvI9

On March 17th, @dano-hta.bsky.social will serve as a panelist at the NICE Conference for a session on "International collaboration to develop health technology assessment methods" with NICE's Nick Crabb, CDA's Nicole Mittmann, and Univ of York's Mark Sculpher. Register here: bit.ly/49PQxGd

ICER #WeeklyView: An IgA Nephropathy Evidence Report, Final Report on smoking cessation, & FDA passes on Moderna’s flu vaccine conta.cc/4amqzKp

Institute for Clinical and Economic Review Publishes Final Evidence Report on Medication for Smoking Cessation: tinyurl.com/yvchubkk

ICER's Chief Medical Officer, @davidrind.bsky.social, sat down with Bobby Dubois of the "Live Long & Well with Dr. Bobby" podcast to discuss GLP-1s for obesity management. Listen now: podcasts.apple.com/us/podcast/6...

Institute for Clinical and Economic Review Releases Evidence Report on Therapies for IgA Nephropathy: tinyurl.com/mumdu8d9

ICER #WeeklyView: TrumpRx launch, PBM reforms, & polling on prior auth conta.cc/3M2YbDD

ICER #WeeklyView: New Governance Board member, CMS CGT Access Model, & Congress’s health care deal conta.cc/4r7k0AP

Institute for Clinical and Economic Review Names Luke Prettol to Governance Board tinyurl.com/4jj4tsbj

ICER #WeeklyView: Smoking cessation public meeting, CMS payment models, & tabelecleucel rejection conta.cc/49zIfAj

ICER #WeeklyView: ICER turns 20, remembering David Mitchell & Stuart Altman conta.cc/45GWDWg

ICER #WeeklyView: The most important ICER stories of 2025 conta.cc/3MDt6q0

Institute for Clinical and Economic Review Publishes Final Evidence Report on Treatments for Obesity: tinyurl.com/nd8y5kvv

ICER #WeeklyView: Smoking cessation Evidence Report, IgAN Draft Evidence Report & rising prescription drug costs conta.cc/4pX81Fg

Institute for Clinical and Economic Review Publishes Evidence Report on Medication for Smoking Cessation: tinyurl.com/5xuk6pza

Institute for Clinical and Economic Review Releases Draft Evidence Report on Therapies for IgA Nephropathy: tinyurl.com/ycyva2tr

ICER #WeeklyView: ICER CEO on RHV Podcast, Medicare negotiated prices, & PBM alternatives emerge conta.cc/3Mfy4ZP

ICER President and CEO Sarah K. Emond joined the @relentleshealth.bsky.social pod to discuss the tensions that exist in drug pricing and how paying for value can help fix them. Listen: cc-lnk.com/EP494. The bonus episode talks about ICER's work and more: cc-lnk.com/EP494-BonusC....

This week ICER marks the 5-year anniversary of ICER Analytics™, our cloud-based platform that has revolutionized the ability of users to develop formularies, negotiate drug prices, and explore new ways to apply ICER’s evidence. Learn more at analytics.icer.org.

ICER #WeeklyView: ICER Analytics is 5, ICER interviewed on GLP-1 pricing, & health benefits costs to increase conta.cc/4ieQnKC

ICER #WeeklyView: This holiday season, consider donating to ICER conta.cc/4oMsVXK

Institute for Clinical and Economic Review Releases Draft Scope on Vaccines for Covid-19: tinyurl.com/4enrmhsf

ICER #WeeklyView: Obesity public meeting, paying for value for obesity meds, & responses to ICER’s Launch Price and Access Report conta.cc/4nLPYAy

ICER #WeeklyView: NCFB and obesity Evidence Reports, Cigna ends rebates, & updated approval for biosimilars conta.cc/4oIRkg6

Institute for Clinical and Economic Review Publishes Final Evidence Report on Treatment for Non-Cystic Fibrosis Bronchiectasis: tinyurl.com/4rmnz269

Institute for Clinical and Economic Review Publishes Evidence Report on Treatments for Obesity: tinyurl.com/3wbemnr9

Today: Join ICER for a conversation around rising launch prices, and the implications for affordability and patient access. Register for the 2025 Launch Price and Access Report: Policy Implications webinar: tinyurl.com/3xukfka2

ICER #WeeklyView: Launch Price and Access Report and webinar, & assessments for narcolepsy and smoking cessation conta.cc/4nhUsP2

New Institute for Clinical and Economic Review Report Shows Significant Jump in Launch Prices, Exceeding Inflation and GDP Growth: tinyurl.com/46swvktj

Institute for Clinical and Economic Review Releases Draft Evidence Report on Treatment for Smoking Cessation: tinyurl.com/3c9n6bkh

Institute for Clinical and Economic Review to Assess Treatment for Narcolepsy: tinyurl.com/2vw57seu

ICER #WeeklyView: Launch Price and Access Report webinar, On Point interview, & California PBM reforms conta.cc/47fZHsJ

ICER #WeeklyView: HEMA Draft Report, ICER’s paper in Health Affairs Scholar, & the Colorado PDAP vote conta.cc/3KIpfXJ

Health Economics Methods Advisory Group Releases Draft Report: Assessing Treatment Benefits in HTA Decision-Making tinyurl.com/yc47dejv

How to make one line in the FDA Commissioner’s new drug review program into a force for affordable access for patients -- a new Health Affairs Scholar paper by ICER President and CEO Sarah Emond and Chief Scientific Officer Dan Ollendorf: tinyurl.com/32bexcd9

ICER #WeeklyView: Vaccines for COVID-19 to be assessed, Trump Administration’s drug pricing announcements, & ACA subsidies conta.cc/4nCjZDy

Institute for Clinical and Economic Review to Assess Vaccines for COVID-19: tinyurl.com/2tfn5pme

ICER #WeeklyView: NCFB public meeting, GLP-1s lower costs, & pharma responses to new regulations conta.cc/3IIbHe7

ICER #WeeklyView: CMS report, GLP-1 cost-effectiveness, & soaring health care costs conta.cc/4mjUh59

Institute for Clinical and Economic Review to Undertake Special Report on Crohn’s Disease and Ulcerative Colitis for CMS as Part of Public Comment Process on Medicare Drug Price Negotiations: tinyurl.com/4urn4xf7

ICER #WeeklyView: Obesity draft evidence report, NCFB evidence report, & a crackdown on pharma ads conta.cc/46wGALw

Institute for Clinical and Economic Review Releases Draft Evidence Report on Treatments for Obesity: tinyurl.com/4zzsd7dw

Institute for Clinical and Economic Review Publishes Evidence Report on Treatment for Non-Cystic Fibrosis Bronchiectasis: tinyurl.com/39by2hs5

ICER #WeeklyView: SMA final evidence report, upcoming GLP-1 draft report & prescription drug reforms conta.cc/3V0BdOo

Institute for Clinical and Economic Review Publishes Final Evidence Report on Treatments for Spinal Muscular Atrophy: tinyurl.com/mw453b9h

ICER #WeeklyView: A note from ICER’s CEO, rising employer health costs, & direct-to-consumer pricing conta.cc/4mV72nD